← Back to Search

Proactive Tobacco Treatment for COPD

N/A
Waitlist Available
Led By Anne C. Melzer, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with COPD (2 ICD-10 diagnoses of COPD within the past 2 years)
Be older than 18 years old
Must not have
Undergoing active cancer treatment
Unable to communicate in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if a proactive, electronic tobacco treatment intervention can help smokers with COPD quit smoking.

Who is the study for?
This trial is for smokers with COPD who are veterans, currently enrolled in MyHealtheVet secure messaging, have had at least one medical visit in the past year, and are confirmed as current smokers. It's not for those already in VA tobacco treatment, non-English speakers, hospice patients, cancer patients under active treatment or individuals with advanced dementia.
What is being tested?
The study is testing an electronic proactive outreach program designed to help smokers with COPD quit smoking. The program will be delivered via text or secure messaging instead of phone calls. Participants will either receive usual care or the new intervention to see if it increases engagement in quitting programs and success rates.
What are the potential side effects?
Since this trial involves a behavioral intervention rather than medication, there aren't typical drug side effects. However, participants may experience stress or frustration related to quitting smoking efforts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with COPD twice in the last 2 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently receiving treatment for cancer.
Select...
I cannot communicate in English.
Select...
My condition is advanced dementia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Response to outreach intervention
Secondary study objectives
Marginal Cost
Number of Quit attempts
Participation in tobacco cessation treatment
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Proactive OutreachExperimental Treatment1 Intervention
Randomly assigned sample who will receive a proactive offer of tobacco treatment with connection to motivational texting program.
Group II: Usual CareActive Control1 Intervention
Randomly assigned sample who will receive usual care for tobacco cessation treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Proactive Outreach
2010
N/A
~20980

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,663 Previous Clinical Trials
3,765,649 Total Patients Enrolled
10 Trials studying Smoking
3,499 Patients Enrolled for Smoking
Anne C. Melzer, MDPrincipal InvestigatorMinneapolis VA Health Care System, Minneapolis, MN
Anne C. Melzer, MD MSPrincipal InvestigatorMinneapolis VA Health Care System, Minneapolis, MN

Media Library

Proactive Outreach Clinical Trial Eligibility Overview. Trial Name: NCT04462289 — N/A
Smoking Research Study Groups: Usual Care, Proactive Outreach
Smoking Clinical Trial 2023: Proactive Outreach Highlights & Side Effects. Trial Name: NCT04462289 — N/A
Proactive Outreach 2023 Treatment Timeline for Medical Study. Trial Name: NCT04462289 — N/A
~24 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top